FDA
-
-
-
-
-
-
-
FDA reclassifies NRx Pharmaceuticals ketamine application amendment
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on NRx Pharmaceuticals, Inc. (NRXP)
-
-
-
-
-
-
-
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
-
-
-
-
-
-
-
HOPE Therapeutics deploys Zeta Surgical's FDA-cleared TMS system
-
-
-
-
-
-
-
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free Ketamine
-
-
-
-
-
-
-
NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications
-
-
-
-
-
-
-
NRx Pharmaceuticals receives FDA guidance for ketamine depression drug
-
335,515 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


